Publication | Open Access

Application of a Two-Analyte Integrated Population Pharmacokinetic Model to Evaluate the Impact of Intrinsic and Extrinsic Factors on the Pharmacokinetics of Polatuzumab Vedotin in Patients with Non-Hodgkin Lymphoma

Lymphoid NeoplasiaOncologyPharmacokinetic ModelingMedicinePolatuzumab VedotinNon-hodgkin LymphomaExtrinsic FactorsPharmacotherapyImmunotherapyPharmacologyRadiation OncologyTumor MicroenvironmentPharmacokinetics